Filed: 5/14/2026ACC: 0002102314-26-000003
📋 What this filing means
JONES HILL CAPITAL LP filed this quarterly 13F‑HR report disclosing 26 equity positions with a total reported market value of $466.47M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
26
Positions
$466.47M
Total AUM (reported)
16.98M
Total Shares
Allocation by class
COM$383.90M82.3%
COM NEW$33.86M7.3%
SPONSORED ADR$18.98M4.1%
COM CL A$10.22M2.2%
CL A$6.70M1.4%
COMMON STOCK$6.37M1.4%
SPONSORED ADS$4.85M1.0%
Portfolio Concentration
Top 3$157.62M33.8%
4–10$183.17M39.3%
11–25$124.63M26.7%
Rest$1.06M0.2%
Top 3 weight
33.8%
Top 10 weight
73.1%
Voting Authority Distribution
Total shares with voting rights: 16.98M
Sole
Full voting authority
16.98M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole26
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings26
Rows:
BIOMARIN PHARMACEUTICAL INC
SOLEShares1.27M
TypeSH
Market value$71.65M
15.36%
Sole
1.27M
Shared
0.00
None
0.00
VERTEX PHARMACEUTICALS INC
SOLEShares108.60K
TypeSH
Market value$48.50M
10.40%
Sole
108.60K
Shared
0.00
None
0.00
VAXCYTE INC
SOLEShares644.83K
TypeSH
Market value$37.47M
8.03%
Sole
644.83K
Shared
0.00
None
0.00
NUVALENT INC
SOLEShares300.83K
TypeSH
Market value$30.82M
6.61%
Sole
300.83K
Shared
0.00
None
0.00
CAPRICOR THERAPEUTICS INC
SOLEShares909.21K
TypeSH
Market value$27.64M
5.93%
Sole
909.21K
Shared
0.00
None
0.00
TERNS PHARMACEUTICALS INC
SOLEShares521.24K
TypeSH
Market value$27.48M
5.89%
Sole
521.24K
Shared
0.00
None
0.00
BICARA THERAPEUTICS INC
SOLEShares1.26M
TypeSH
Market value$25.06M
5.37%
Sole
1.26M
Shared
0.00
None
0.00
ANI PHARMACEUTICALS INC
SOLEShares318.59K
TypeSH
Market value$24.50M
5.25%
Sole
318.59K
Shared
0.00
None
0.00
ULTRAGENYX PHARMACEUTICAL IN
SOLEShares1.17M
TypeSH
Market value$24.42M
5.23%
Sole
1.17M
Shared
0.00
None
0.00
ENLIVEN THERAPEUTICS INC
SOLEShares593.04K
TypeSH
Market value$23.25M
4.98%
Sole
593.04K
Shared
0.00
None
0.00
AMYLYX PHARMACEUTICALS INC
SOLEShares1.60M
TypeSH
Market value$22.22M
4.76%
Sole
1.60M
Shared
0.00
None
0.00
ARGENX SE
SOLEShares26K
TypeSH
Market value$18.98M
4.07%
Sole
26K
Shared
0.00
None
0.00
FULCRUM THERAPEUTICS INC
SOLEShares1.77M
TypeSH
Market value$13.59M
2.91%
Sole
1.77M
Shared
0.00
None
0.00
VIR BIOTECHNOLOGY INC
SOLEShares1.20M
TypeSH
Market value$10.74M
2.30%
Sole
1.20M
Shared
0.00
None
0.00
NUVATION BIO INC
SOLEShares2.38M
TypeSH
Market value$10.22M
2.19%
Sole
2.38M
Shared
0.00
None
0.00
ORUKA THERAPEUTICS INC
SOLEShares140.84K
TypeSH
Market value$6.91M
1.48%
Sole
140.84K
Shared
0.00
None
0.00
CONTINEUM THERAPEUTICS INC
SOLEShares513.05K
TypeSH
Market value$6.70M
1.44%
Sole
513.05K
Shared
0.00
None
0.00
VERADERMICS INC
SOLEShares100.84K
TypeSH
Market value$6.37M
1.37%
Sole
100.84K
Shared
0.00
None
0.00
TONIX PHARMACEUTICALS HLDG C
SOLEShares452.12K
TypeSH
Market value$6.22M
1.33%
Sole
452.12K
Shared
0.00
None
0.00
STRUCTURE THERAPEUTICS INC
SOLEShares100.59K
TypeSH
Market value$4.85M
1.04%
Sole
100.59K
Shared
0.00
None
0.00
ENTRADA THERAPEUTICS INC
SOLEShares374.01K
TypeSH
Market value$4.72M
1.01%
Sole
374.01K
Shared
0.00
None
0.00
PHARVARIS N V
SOLEShares167.01K
TypeSH
Market value$4.72M
1.01%
Sole
167.01K
Shared
0.00
None
0.00
TREVI THERAPEUTICS INC
SOLEShares370.18K
TypeSH
Market value$4.42M
0.95%
Sole
370.18K
Shared
0.00
None
0.00
RELMADA THERAPEUTICS INC
SOLEShares342.75K
TypeSH
Market value$2.39M
0.51%
Sole
342.75K
Shared
0.00
None
0.00
SILENCE THERAPEUTICS PLC
SOLEShares301.60K
TypeSH
Market value$1.59M
0.34%
Sole
301.60K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
BIOMARIN PHARMACEUTICAL INCSOLE | COM | 1.27M | SH | $71.65M 15.36% | 1.27M | 0.00 | 0.00 |
VERTEX PHARMACEUTICALS INCSOLE | COM | 108.60K | SH | $48.50M 10.40% | 108.60K | 0.00 | 0.00 |
VAXCYTE INCSOLE | COM | 644.83K | SH | $37.47M 8.03% | 644.83K | 0.00 | 0.00 |
NUVALENT INCSOLE | COM | 300.83K | SH | $30.82M 6.61% | 300.83K | 0.00 | 0.00 |
CAPRICOR THERAPEUTICS INCSOLE | COM NEW | 909.21K | SH | $27.64M 5.93% | 909.21K | 0.00 | 0.00 |
TERNS PHARMACEUTICALS INCSOLE | COM | 521.24K | SH | $27.48M 5.89% | 521.24K | 0.00 | 0.00 |
BICARA THERAPEUTICS INCSOLE | COM | 1.26M | SH | $25.06M 5.37% | 1.26M | 0.00 | 0.00 |
ANI PHARMACEUTICALS INCSOLE | COM | 318.59K | SH | $24.50M 5.25% | 318.59K | 0.00 | 0.00 |
ULTRAGENYX PHARMACEUTICAL INSOLE | COM | 1.17M | SH | $24.42M 5.23% | 1.17M | 0.00 | 0.00 |
ENLIVEN THERAPEUTICS INCSOLE | COM | 593.04K | SH | $23.25M 4.98% | 593.04K | 0.00 | 0.00 |
AMYLYX PHARMACEUTICALS INCSOLE | COM | 1.60M | SH | $22.22M 4.76% | 1.60M | 0.00 | 0.00 |
ARGENX SESOLE | SPONSORED ADR | 26K | SH | $18.98M 4.07% | 26K | 0.00 | 0.00 |
FULCRUM THERAPEUTICS INCSOLE | COM | 1.77M | SH | $13.59M 2.91% | 1.77M | 0.00 | 0.00 |
VIR BIOTECHNOLOGY INCSOLE | COM | 1.20M | SH | $10.74M 2.30% | 1.20M | 0.00 | 0.00 |
NUVATION BIO INCSOLE | COM CL A | 2.38M | SH | $10.22M 2.19% | 2.38M | 0.00 | 0.00 |
ORUKA THERAPEUTICS INCSOLE | COM | 140.84K | SH | $6.91M 1.48% | 140.84K | 0.00 | 0.00 |
CONTINEUM THERAPEUTICS INCSOLE | CL A | 513.05K | SH | $6.70M 1.44% | 513.05K | 0.00 | 0.00 |
VERADERMICS INCSOLE | COMMON STOCK | 100.84K | SH | $6.37M 1.37% | 100.84K | 0.00 | 0.00 |
TONIX PHARMACEUTICALS HLDG CSOLE | COM NEW | 452.12K | SH | $6.22M 1.33% | 452.12K | 0.00 | 0.00 |
STRUCTURE THERAPEUTICS INCSOLE | SPONSORED ADS | 100.59K | SH | $4.85M 1.04% | 100.59K | 0.00 | 0.00 |
ENTRADA THERAPEUTICS INCSOLE | COM | 374.01K | SH | $4.72M 1.01% | 374.01K | 0.00 | 0.00 |
PHARVARIS N VSOLE | COM | 167.01K | SH | $4.72M 1.01% | 167.01K | 0.00 | 0.00 |
TREVI THERAPEUTICS INCSOLE | COM | 370.18K | SH | $4.42M 0.95% | 370.18K | 0.00 | 0.00 |
RELMADA THERAPEUTICS INCSOLE | COM | 342.75K | SH | $2.39M 0.51% | 342.75K | 0.00 | 0.00 |
SILENCE THERAPEUTICS PLCSOLE | ADS | 301.60K | SH | $1.59M 0.34% | 301.60K | 0.00 | 0.00 |
Page 1 of 2